Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Baraa, Alosh"'
Autor:
Vidya Patil, Julie J. Ruterbusch, Wei Chen, Julie L. Boerner, Eman Abdulfatah, Baraa Alosh, Visakha Pardeshi, Asra N. Shaik, Sudeshna Bandyopadhyay, Rouba Ali-Fehmi, Michele L. Cote
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The risk of developing subsequent breast cancer is higher in women diagnosed with benign breast disease (BBD) but these studies were primarily performed in non-Hispanic white populations. Still, these estimates have been used to inform breast cancer
Externí odkaz:
https://doaj.org/article/77dd82f1cac84200a4535a57320db267
Autor:
Baraa Alosh, Sudeshna Bandyopadhyay, Martin H. Bluth, Eman Abdulfatah, Quratulain Ahmed, Rouba Ali-Fehmi
Publikováno v:
Clinics in Laboratory Medicine. 38:421-438
Ovarian carcinoma continues to be a concern for woman and maintains significant morbidity and mortality. Emerging molecular markers are providing additional opportunities for effective diagnosis and prognosis of disease. An integrated clinicopatholog
Publikováno v:
The American journal of gastroenterology. 115(2)
Autor:
Koen Van de Vijver, Baraa Alosh, Rouba Ali-Fehmi, Eman Abdulfatah, Sudeshna Bandyopadhyay, Esther Oliva, Muhammad Khurram, Leonardo Lordello
Publikováno v:
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 38(3)
Uterine carcinosarcomas are rare aggressive biphasic neoplasms. Because of its rarity, limited data are available on potential prognostic parameters. While several studies support that carcinomatous components predict outcomes, others do not. In this
Autor:
Eman, Abdulfatah, Quratulain, Ahmed, Baraa, Alosh, Sudeshna, Bandyopadhyay, Martin H, Bluth, Rouba, Ali-Fehmi
Publikováno v:
Clinics in laboratory medicine. 38(2)
Ovarian carcinoma continues to be a concern for woman and maintains significant morbidity and mortality. Emerging molecular markers are providing additional opportunities for effective diagnosis and prognosis of disease. An integrated clinicopatholog
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Baraa Alosh, Greg Dyson, Rouba Ali-Fehmi, Nallasivam Palanisamy, Lydia Choi, Sandeep Mittal, Aliccia Bollig-Fischer, Adele Kruger, Sharon K. Michelhaugh, Priyanga Wijesinghe
Publikováno v:
Europe PubMed Central
Oncotarget
Scopus-Elsevier
Oncotarget
Scopus-Elsevier
// Aliccia Bollig-Fischer 1, 5 , Sharon K. Michelhaugh 2, 5 , Priyanga Wijesinghe 1, 5 , Greg Dyson 1, 5 , Adele Kruger 3 , Nallasivam Palanisamy 6 , Lydia Choi 1, 5 , Baraa Alosh 4 , Rouba Ali-Fehmi 4, 5 , Sandeep Mittal 1, 2, 5 1 Department of Onco
Autor:
Rouba Ali-Fehmi, Susanna D. Mitro, Sudeshna Bandyopadhyay, Baraa Alosh, Julie J. Ruterbusch, Derek C. Radisky, Marlene H. Frost, Michele L. Cote, Amy C. Degnim, Bassam Albashiti
Publikováno v:
The Breast Journal. 20:571-577
Benign breast disease (BBD) is a very common condition, diagnosed in approximately half of all American women at some point in their lives (1). Along with age, reproductive factors and family history, it is well established that BBD raises long-term
Publikováno v:
Clinics in Laboratory Medicine. 33:911-925
This article reviews the molecular features and pathogenesis of gynecologic malignancies. Understanding the molecular basis of endometrial carcinoma helps to provide an explanation for the prognosis of these tumors and opens up avenues for research i
Autor:
Robert T. Morris, Daniel Schultz, Yaser R. Hussein, Marisa R. Nucci, Baraa Alosh, Ira Winer, Esther Oliva, Rouba Ali-Fehmi, Faisal Quershi, Adnan R. Munkarah, Sudeshna Bandyopadhyay, Koen Van de Vijver, Farah Tabassum, Haider Mahdi, Kinda Hayek, Assaad Semaan, Michele L. Cote, Ismail Mert
Publikováno v:
International Journal of Gynecological Pathology, 32(2), 181-187. LIPPINCOTT WILLIAMS & WILKINS
The objective of this study was to analyze the clinical and pathologic factors in patients with uterine serous carcinoma confined to the endometrium. A total of 236 uterine serous carcinoma patients from the pathology databases of 4 large academic in